SELEXEL
SeleXel is a biotechnology company whose mission is to develop efficient therapeutic solutions in Oncology using a very innovative technology: RNA interference. This natural biological mechanism allows to very specifically impair the synthesis of proteins required for the development of a cancer. SeleXel concentrates its initial efforts on the development of drugs treating prostate cancers that became resistant to conventional hormonal treatments. The company develops a portfolio of siRNAs blocking cancer spreading (metastasis), and restoring the ability of the immune system to eliminate the tumor.
SELEXEL
Industry:
Biotechnology
Founded:
2006-01-01
Address:
Toulouse, Midi-Pyrenees, France
Country:
France
Website Url:
http://www.selexel.com
Total Employee:
11+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Contact Form 7 WordPress 6.0
Similar Organizations
1st Human Therapeutics
1st Human Therapeutics is a biotechnology company focused on developing first-in-human therapeutics.
Investors List
AGORANOV
AGORANOV investment in Venture Round - Selexel
Official Site Inspections
http://www.selexel.com
- Host name: node24-eu.n0c.com
- IP address: 185.221.182.101
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
